INHIBITEURS MARQUÉS 18F DE L'ANTIGÈNE MEMBRANAIRE SPÉCIFIQUE DE LA PROSTATE (PSMA), LEUR UTILISATION COMME AGENTS D'IMAGERIE ET AGENTS PHARMACEUTIQUES POUR LE TRAITEMENT DU CANCER DE LA PROSTATE
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer.